Antimicrobial resistance is on the rise in Europe and elsewhere in the world. We are losing our first-line antimicrobials. Replacement treatments are more costly, more toxic, need much longer durations of treatment, and may require treatment in intensive care units.
Authorization is only required to store your personal settings and favorites.
Log in with:
Use this code for embedding the Quote anywhere
